Member Info for Laura2022

Fact he's asked for 0.5% is telling

Why add that if there wasn't clear signs the end of road is near

You don't need to worry uncanny as you sold

Josh

What were the main takeaways from the presentation which you liked?

Also...the sp has been 0.65p/7 for 3mths ..so hardly "fallen"

Nice try

"It's with the lawyers"

37th minute

Now we know what he meant with that:)

Andy

We've always said that VAL201 will simply be an added bonus to the growing revenues and strategic initiatives

Therefore PYC are not dependent on its outcome

Mark has delivered

He said

1) update in 2 weeks

2) time clock on THX

3) THEN will assess VAL need for funding

So

..yet again Porky having said placing for March, April, May, June,July, Aug, Sept will simply roll on his bet

Eg this was the original 2021 RNS fron VAL which contains AND ALWAYS HAS contained that understandable legal caveat.

Under this proposed Licence Agreement, TheoremRx will obtain a worldwide licence to ValiRx's VAL201 intellectual property for a novel peptide targeting SRC kinase targeting oncology indications. ValiRx will retain the rights to develop the VAL201 peptide for non-oncology indications, including VAL301 for endometriosis. Subject to successful market authorisation, the potential value of the deal would be in excess of US$61M plus royalties for the first cancer indication alone. Each oncology indication successfully developed to by TheoremRx will generate up to $37.5M of additional value to ValiRx. The proposed deal structure comprises payments on signature of the Licence Agreement plus fees and near-term milestones totalling US$2.2M before the end of 2023, milestones on further clinical and commercial development events, and royalties. The first payments are expected by the end of 2021.

As part of the deal, TheoremRx will enter into a service contract with ValiRx to provide consulting services to TheoremRx to aid technology transfer, formulation for patent extension and continued clinical development of VAL201. 

The LOI details a period of exclusivity during which TheoremRx will complete its due diligence on the scientific and commercial attributes of VAL201, during which ValiRx is restricted from continuing to market the programme to other parties. Completion of the Licence Agreement is also subject to terms and conditions at closing.

The LOI and proposed Licence Agreement therefore remain non-binding and there is no guarantee that this Licence Agreement will be executed or that it will generate material revenues within the expected timeframe or at all.

Andy

That legal caveat is normal for any deal like this and has been the case for VAL and any other company

Hopefully those who have lied and spread false info will look at GEX

When i spoke to Mark in summer I alerted him to several names here

Well done Gex

Thought it was suspicious when 5 new accounts popped up yesterday spreading lies across AIm

This time limited extension has been granted to allow TheoremRx to continue the progression of their financing, which on completion will enable execution of the sub-license of VAL201 to TheoremRx

Looks like Uncanny etc caught out again

VAL to get 0.5% equity in enlarged company

Great negotiations Mark

He impressed me at the presentation

Up to £6mlm for PYC

ValiRx PLC ("ValiRx" or the "Company")

 

Update on proposed sub-license of VAL201

 

London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health announces that, further to the 2024 interim results announced on 27 September 2024, the Company has signed an amendment to the Letter of Intent ("LOI") with TheoremRx Inc ("TheoremRx"). The exclusivity provided has been extended for a limited time period until 31 December 2024 in exchange for a 0.5% equity interest in TheoremRx following the potential reversal into a US listed shell.

ValiRx PLC ("ValiRx" or the "Company")

Update on proposed sub-license of VAL201

London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health announces that, further to the 2024 interim results announced on 27 September 2024, the Company has signed an amendment to the Letter of Intent ("LOI") with TheoremRx Inc ("TheoremRx"). The exclusivity provided has been extended for a limited time period until 31 December 2024 in exchange for a 0.5% equity interest in TheoremRx following the potential reversal into a US listed shell.

Please read the annual report

In the presentation they talked of longer and more substantial opportunities for contracts from the new division

The average contract size has almost trebled over the last 12mths so it's not beyond realms of possibly that PYC could soon be winning £200k-400k + long term contracts going forward

This was from results to June 2024

Implementation of the Company’s Personalised Dosing Software onto DoseMe’s newly launched platform, allowing access to the software for research purposes initially, with the aim to add paid for functionality later• Awarded two large contracts exceeding £286k, in aggregate, with two new clients, one of whom is at the forefront of AI driven drug discovery• Follow-on contracts with Bicycle Therapeutics, Numab Therapeutics, Merck KGaA and Sheffield University exceeding, in aggregate, £822k•

Yes - there are contracts but they are small and mainly one-offs

Josh...

Wrong on 2 counts

1 most repeat business

2 average size grown x 3 in last 12mths

Please at least research properly

Joshing man

Make your mind up

joshing_man

Posted in: PYC

Posts: 631

Price: 0.725

No Opinion

RE: Means of profit and progress30 Aug 2024 17:24

Thanks again Laura - sterling effort and very helpful. Hopefully Monday I can add some more albeit not huge amounts but it all helps!

The placing shares were cleared ages ago (mid August there were x 3 the placing shares traded in one week

Well..it was hard /impossible to buy at various points in the afternoon at 0 65p so I would think, against logic , many were buys

Kione

I'm invested!! And have been since 9p

How can i be a de -ramper !!